OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 78 filers reported holding OCULAR THERAPEUTIX INC in Q4 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $736 | -3.0% | 142,822 | -0.8% | 0.00% | 0.0% |
| Q1 2023 | $759 | +1165.0% | 144,030 | +570.6% | 0.00% | – |
| Q4 2022 | $60 | -100.0% | 21,479 | -58.2% | 0.00% | – |
| Q3 2022 | $213,000 | +150.6% | 51,385 | +141.5% | 0.00% | – |
| Q2 2022 | $85,000 | +269.6% | 21,277 | +342.4% | 0.00% | – |
| Q1 2022 | $23,000 | -81.9% | 4,809 | -73.7% | 0.00% | – |
| Q4 2021 | $127,000 | -71.4% | 18,297 | -41.0% | 0.00% | – |
| Q3 2021 | $444,000 | +10.7% | 31,006 | +9.6% | 0.00% | – |
| Q2 2021 | $401,000 | – | 28,301 | -16.4% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 33,850 | -15.6% | 0.00% | -100.0% |
| Q4 2020 | $829,000 | +2338.2% | 40,093 | +787.2% | 0.00% | – |
| Q3 2020 | $34,000 | -87.6% | 4,519 | -86.3% | 0.00% | – |
| Q2 2020 | $274,000 | +568.3% | 32,948 | +291.0% | 0.00% | – |
| Q1 2020 | $41,000 | -76.0% | 8,427 | -80.6% | 0.00% | – |
| Q4 2019 | $171,000 | +180.3% | 43,537 | +114.0% | 0.00% | – |
| Q3 2019 | $61,000 | -84.7% | 20,345 | -77.5% | 0.00% | -100.0% |
| Q2 2019 | $398,000 | +1272.4% | 90,518 | +1108.0% | 0.00% | – |
| Q4 2018 | $29,000 | -79.3% | 7,493 | -63.4% | 0.00% | – |
| Q3 2018 | $140,000 | +1172.7% | 20,452 | +961.3% | 0.00% | – |
| Q3 2017 | $11,000 | -88.5% | 1,927 | -83.3% | 0.00% | -100.0% |
| Q4 2016 | $96,000 | +104.3% | 11,557 | +20.7% | 0.01% | +100.0% |
| Q2 2016 | $47,000 | +4.4% | 9,574 | +99.0% | 0.00% | -25.0% |
| Q4 2015 | $45,000 | +542.9% | 4,810 | +834.0% | 0.00% | +300.0% |
| Q3 2015 | $7,000 | – | 515 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
| Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
| DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
| Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
| Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
| SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
| Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
| EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
| EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
| RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |